Abstract

CoMiSSTM is a clinical tool developed to increase awareness among healthcare professionals (HCP) of possible symptoms of cow’s milk allergy (CMA) in infants. During this symposium, leading experts in the field of paediatric gastroenterology, allergy, and nutrition highlighted how CoMiSS can facilitate awareness of CMA and support HCPs in improving the patient journey from symptom presentation to diagnosis. Rosan Meyer, Imperial College London, UK; Winchester University, Hampshire, UK; and Katholieke Universiteit (KU) Leuven, Belgium, summarised the major challenges of CMA diagnosis, which underscore the need for improved clinical tools to increase HCP awareness of hallmark symptoms. Katerina Bajerova, Katholieke Universiteit (KU) Leuven, Belgium, and Department of Pediatrics, University Hospital, Brno, Czechia, reviewed the current evidence base for CoMiSS and presented key learnings from recent clinical experience using this tool. Yvan Vandenplas, KidZ Health Castle, University Hospital Brussels (UZ Brussel), Belgium, showcased the latest updates to CoMiSS for 2022 proposed by the expert consensus panel and explained how these improvements would help increase the application of CoMiSS in raising CMA awareness.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call